Full Press Release Details
Z. Rosengart Notifies Dyadic International, Inc. of His Resignation
Fla. - June 19, 2008 - Dyadic International, Inc. (the "Company") announced
today that, on June 13, 2008, Harry Z. Rosengart notified the Company of his
resignation (i) as the Chairman of the Board of Directors (the "Board") and as
the Chairman of the Executive Committee of the Board (the "Executive Committee")
of the Company effective June 18, 2008 (following the Executive Committee
meeting held on such date), and (ii) as a director of the Company effective at
12:00 p.m. on June 20, 2008. On June 18, 2008, Wendell H. Adair, Jr.
was elected as the Chairman of the Board and as the Chairman of the Executive
Committee, replacing Mr. Rosengart.
19, 2008, the Company filed with the Securities and Exchange Commission a
Current Report on Form 8-K, which includes a copy of this press release as an
International, Inc. is a biotechnology company that uses its patented and
proprietary technologies to conduct research and development activities for the
discovery, development, and manufacture of products and enabling solutions to
the bioenergy, industrial enzyme and pharmaceutical industries.
Relations Counsel to Dyadic International, Inc., 310-826-5051